A new choleretic effect of folinic acid

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1442-1445

  Kajiyama, Y ^a   Tsurumaru, M ^a   Udagawa, H ^a   Tsutsumi, K ^a   Kinoshita, Y ^a   Ueno, M ^a   Akiyama, H ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLERETIC AGENT; FOLINIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BILE; BILE DUCT; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BILE; BILE ACIDS AND SALTS; CHOLAGOGUES AND CHOLERETICS; LEUCOVORIN; MALE; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 0031769219     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stryner, L: Biochemistry. New York: W.H. Freeman 1981; 491-494.
2. Machover D, Schwarzenberg L, Goldschmidt E: Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high dose folinic acid: A pilot study. Cancer Treat Rep 1982; 66:1803-1807.
3. Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, Fourtillan JB, Gaget H, Mathe G: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncl 1986; 4:685-696.
4. O'Conell MJ: A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer 1989; 63:1026-1030.
5. Ulman B, Lee M, Martin DW, Santi DV: Cytotoxicity of 5-fluoro-2'-deoxyuridine: Requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 1978; 75:980-983.
6. Kajiyama Y, Tsurumaru M, Udagawa H, Tsutsumi K, Kinoshita Y, Akiyama H: Relief of jaundice by 5-fluorouracil and folinic acid in patients with recurrent gastric cancer. Surg Oncol 1996; 5:177-181.
7. Waynforth HB, Flecknell PA: Experimental and surgical technique in the rat. London: Academic press 1992; 206-209.
8. Schilsky RL, Choi KE, Vokes EE, Guaspari A, Guarnieri C, Whaling S, Liebner MA: Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing. Cancer 1989; 63:1018-1021.
9. Perry MC: Hepatotoxicity of chemotherapeutic agents. Sem in Oncol 1982; 9:65.
10. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Lourie JA: Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncl 1993; 11:2386-2390.
11. Boyer JL, Bloomer JR: Canalicular bile secretion in man. Studies utilizing biliary clearance of (14C) mannitol. J Clin Invest 1974; 54:773-781.
12. Balabaud C, Kron KA, Gamucio JJ: The assessment of the bile salt-nondependent fraction of canalicular bile water in the rat. J Lab Clin Invest 1977; 89:393-399.
13. Van Dyke RW, Stephens JE, Scharschmidt BF: Effects of ion substitution on bile acid-dependent and -independent bile formation by rat liver. J Clin Invest 1982; 70:505-517.
14. Reynolds MA, Siow Y, Collet D, Klar E, Richardson JD, Vitale GC: The role of bile acid secretion in the hepatic response to operation and infection. The American Surgeon 1995; 61:469-474.
15. Reihner E, Bjorkhem I, Angekin BO, Ewerth S, Einarsson K: Bile acid synthesis in humans: Regulation of hepatic microsomal cholesterol 7-hydroxylase activity. Gastroenterology 1989; 97:1498-1505.
16. Vlahcevic ZR, Heuman DM, Hylemon PB: Regulation of bile acid synthesis. Hepatology 1991; 13:590-600.